Cencora solution

Health authority interactions

We help life sciences teams navigate health authority interactions across development, review, and post-approval with clear strategy and actionable guidance.
Available for
  • Pharma
Available in
  • Global
Related capabilities
  • Commercialization support

Strengthen your agency engagement strategy

The value of health authority engagement depends on choosing the right interaction, asking focused questions, and engaging when your evidence is mature enough to support meaningful feedback.

Cencora combines regulatory strategy, cross-functional content development, meeting preparation, and global coordination to help you identify development risks, clarify expectations, and act on agency advice.

Avoid the missteps that can weaken your agency engagement

Health authority engagement rewards preparation and exposes gaps in execution. With regulatory strategy and program management across regions, Cencora helps you address the pressures that most affect outcomes.
Global coordination
Programs increasingly require sequenced engagement with multiple authorities, with regional advice reconciled into one executable global development plan. 
Implementing advice
Translating health authority feedback into the right development decisions takes experienced regulatory judgment. 
Cross-functional alignment
Clinical, nonclinical, CMC, quality, statistics, safety, and device positions must be integrated before presenting questions to an authority. 

Proven regulatory strategy across every major agency

Cencora supports interactions across the FDA, EMA scientific committees, and national agencies worldwide, from early scientific advice through post-approval follow-up. 

We can help you set strategy, prepare and lead meetings, and turn agency feedback into clear next steps, drawing on local regulatory experts.

What we offer

Scientific advice and early engagement

PRIME eligibility, orphan designation, protocol assistance, pediatric development, and accelerated regulatory pathways in key markets.

FDA meetings

Strategy and execution across pre-IND, end of phase, pre-NDA, Type A, B, C, D, and biosimilar meetings.

EMA and committee interactions

Engagement with SAWP, CHMP, PRAC, COMP, PDCO, and CAT, as well as national health authorities across key markets. 

Medical device and product interactions

Q-Submission and Pre-Submission support, CBER submissions, human factors, and combination product strategy.

Meeting preparation

Regulatory strategy, briefing package authoring, delegate coaching, and rehearsal to ensure your team is fully prepared. 

Follow-up and implementation

Interpretation of agency responses, meeting minutes, and translation of advice into program strategy and next steps. 

Why choose Cencora for health authority interactions

Integrated content development

Clinical, nonclinical, CMC, quality, and safety specialists build one aligned position before your questions ever reach an authority.

Coordinated global engagement

One team sequences interactions across the FDA, EMA, and national agencies and reconciles their advice into a single plan.

Rapidly assembled expertise

Experienced regulatory teams come together quickly around your program, so engagement timelines are not held up by staffing gaps.

Expert insight

Proactive, credible engagement with global health authorities signals that a biotech is not only developmentally sound but also commercially viable.

— Michael Day, PhD

Breaking through early development challenges: BIO panel takeaways

Related solutions

Integrated submission readiness assessment
Navigate NDA, BLA, and MAA submissions with cross-functional regulatory support and an independent readiness assessment before filing.
  • Commercialization support
  • Pharma
  • Global
Regulatory writing
Turn complex scientific, clinical, and quality data into clear, accurate, submission-ready documents across development and lifecycle management.
  • Commercialization support
  • Pharma
  • Global
Safety monitoring and signal detection
Strengthen signal detection and safety monitoring with tailored review, validation, assessment, and action support across your pharmacovigilance activities.
  • Commercialization support
  • Pharma
  • Global

Related resources

Article

How to think like a regulator before you submit your marketing application
Businessman with glasses using his laptop in a sleek modern office space

Report

Overcoming regulatory, pharmacovigilance, and market-access roadblocks to European expansion
Shot of a programmer working on a computer code at night

Article

The potential of AI as a strategic lever for innovation and regulatory decision-making

PharmaLex is now Cencora

Health authority interactions is part of our Commercialization support capability. Same team, same expertise, now with greater reach.
 

Need more information about health authority interactions?

Our team of experts is here to assist you. Whether you have questions or need more detailed information, don’t hesitate to get in touch. We’re dedicated to providing the support you need.